A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

Por um escritor misterioso

Descrição

medRxiv - The Preprint Server for Health Sciences
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Frontiers Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity - ScienceDirect
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity - ScienceDirect
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Metabolomics study of COVID-19 patients in four different clinical stages
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A time-resolved proteomic and prognostic map of COVID-19 - ScienceDirect
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function, Journal of Translational Medicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives
de por adulto (o preço varia de acordo com o tamanho do grupo)